Author:
Hashemi Alireza,Khabazkhoob Mehdi,Narooei Foroozan,Mortazavi Abolghasem,Hashemi Hassan
Abstract
Abstract
Purpose
The present study was conducted to determine the corneal topographic indices of Scheimpflug camera in type 2 diabetes patients without diabetic retinopathy (DR), DR and non-diabetic elderly populations.
Methods
A total of 1105 participants were selected using random cluster sampling from Tehran, Iran and categorized into three groups including type 2 diabetes patients without diabetic retinopathy (DR), DR and non-diabetic. The diabetic group had HbA1c levels ≥ 6.4% with no other systemic problems. The non-diabetic participants had normal eye findings and no systemic diseases. The pachymetric progression index (PPI) values were measured using the Pentacam AXL.
Results
A total of 1105 participants including 429 diabetes patients (38.46% male) and 676 non-diabetic (38.76% male) subjects entered the study. Only PPIavg and PPImax were higher in the diabetics versus non-diabetics (P = 0.019 and 0.010, respectively). There was a significant difference in PPImax between the three groups (P = 0.036). There were significant differences only in index of vertical asymmetry (IVA), central keratoconus index (CKI), PPI average, and PPI max between different stages of diabetic retinopathy (DR) (P = 0.045, 0.005, 0.002, and 0.004, respectively). There was a significant difference in index of Surface Variance (ISV), index of vertical asymmetry (IVA), PPIavg, and PPImax between diabetes patients with and without DR (P = 0.016, 0.022, < 0.001, and < 0.001, respectively).
Conclusion
According to the results, diabetes and DR change several topographic indices. In addition, the HbA1c level may affect pachymetric progression index max. Therefore, special attention should be paid to these patients for different treatment strategies.
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology,General Medicine
Reference25 articles.
1. Xie J, Wang M, Long Z, Ning H, Li J, Cao Y, Liao Y, Liu G, Wang F, Pan A. Global burden of type 2 Diabetes in adolescents and young adults, 1990–2019: systematic analysis of the global burden of Disease Study 2019. BMJ (Clinical Research ed). 2022;379:e072385.
2. Eijaz S, Lalpuria S, Afzal M, Yasmeen A, Saleem S, Begum A. Prevalence of Complications Associated with Diabetes among Pakistani patients: a questionnaire-based Survey. Curr Diabetes Rev. 2022;18(9):e190122200353.
3. Causes of blindness and vision impairment. In 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to Sight: an analysis for the global burden of Disease Study. The Lancet Global Health. 2021;9(2):e144–60.
4. Yılmaz YC, Hayat Ş, İpek ŞC. Analysis of corneal and Lens Densitometry Changes in the type 1 Diabetes Mellitus patients. Am J Ophthalmol 2023.
5. Yang Y, Chai H, Ding Z, Tang C, Liang Y, Li Y, Liang H. Meta-analysis of corneal endothelial changes after phacoemulsification in diabetic and non-diabetic patients. BMC Ophthalmol. 2023;23(1):174.